Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05525572 · ClinicalTrials.gov registry record · Phase 1

Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)

A Phase 1 study, sponsored by University of Miami.

Terminated
Registry status
Phase 1
Development phase
2
Enrollment target

NCT05525572 is a Phase 1 study that was terminated before completion, run by University of Miami. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05525572, a Phase 1 study, was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
Phase 1
Development phase
2 participants
Enrollment target

Study Summary

The purpose of this research study is to evaluate whether the combination of Shockwave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function in diabetics patients.

Interventions

  • DEVICE Shockwave Therapy (SWT)
  • DRUG Autologous Platelet-Rich Plasma (PRP)

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2024-02-12
Est. Completion 2024-08-02
Phase Phase 1

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05525572

The ClinicalTrials.gov registry entry for NCT05525572 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Shockwave Therapy (SWT) is the first listed.

NCT05525572 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05525572 about?

NCT05525572 is a clinical study titled "Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)". The purpose of this research study is to evaluate whether the combination of Shockwave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function in diabetics patients.

What is the current status of trial NCT05525572?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2024-02-12. Estimated completion is 2024-08-02.

What interventions are being tested in trial NCT05525572?

The interventions under investigation include: Shockwave Therapy (SWT) (DEVICE), Autologous Platelet-Rich Plasma (PRP) (DRUG).

Who is sponsoring clinical trial NCT05525572?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.